Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07874841
PHASE4

Varenicline for Smoking Cessation in Pancreatitis

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

This study will look at how safe and how effective varenicline, a commonly used medication for smoking cessation, is in helping patients with pancreatitis stop smoking cigarettes. Individuals who agree to be part of the study will be treated with varenicline for 12 weeks, after which the investigators will see how many have stopped smoking.

Official title: Varenicline for Smoking Cessation in Pancreatitis: An Open-Label Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

45

Start Date

2026-11-13

Completion Date

2029-11-01

Last Updated

2026-10-19

Healthy Volunteers

No

Interventions

DRUG

Varenicline (VAR)

Varenicline is the treatment being offered in this treatment. Treatment will entail oral varenicline 1 mg twice a day (BID) for a total of 12 weeks. Initial titration begins in the following manner: * Days 1-3: 0.5 mg once daily * Days 4-7: 0.5 mg twice daily * Day 8 through end of treatment (12 weeks): 1 mg twice daily

Locations (1)

Mayo Clinic

Rochester, Minnesota, United States